Repurposing fluphenazine as an autophagy modulator for treating liver cancer

Repurposing fluphenazine as an autophagy modulator for treating liver cancer

Hepatocellular carcinoma (HCC) is a common malignant tumor of the digestive system with a low early diagnosis rate. Owing to the side effects, tolerance, and patient contraindications of existing therapies, effective drug treatments for HCC remain a major clinical challenge. However, using approved...

Cijeli opis

Bibliografski detalji
Glavni autori: Chang Su, Cai-yan Cheng, Zheng Rong, Jing-cheng Yang, Zhi-mei Li, Jing-yue Yao, An Liu, Le Yang, Ming-gao Zhao
Format: Članak
Jezik:English
Izdano: Elsevier 2023-12-01
Serija:Heliyon
Teme:
Hepatocellular carcinoma
Connectivity map
Fluphenazine
Autophagy
Drug repurposing
Chronic pain
Online pristup:http://www.sciencedirect.com/science/article/pii/S2405844023098134

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023098134

Slični predmeti